Immunization News and Research

RSS

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

28 Sep 2021

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

In a recent study, researchers from Texas assessed the incidence of new SARS-CoV-2 variants of concern in the communities in Dallas-Fort Worth (DFW).

28 Sep 2021

Pfizer-BioNTech’s COVID-19 vaccine appears effective against SARS-CoV-2 mu variant

Researchers in Japan have conducted a study showing that the vaccine developed by Pfizer-BioNTech to protect against coronavirus disease 2019 (COVID-19) seems to be adequately effective against the B.1.621 (mu) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

27 Sep 2021

Enterovirus 71 vaccine candidate strains exhibit good immunogenicity and cross-neutralization activity

Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.

27 Sep 2021

Trial of Sanofi/GSK SARS-CoV-2 vaccine boosters against variants in non-human primates

New research discusses the development of soluble prefusion-stabilized spike trimers (CoV2 preS dTM) comprising adjuvant AS03.

27 Sep 2021

Who qualifies for a covid booster? The list is growing longer

On Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of coronavirus infection qualify for a shot to boost the protection of their covid-19 vaccination.

27 Sep 2021

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Global leaders attending the Global COVID-19 Summit hosted by the United States have again underlined their commitment to ensuring equitable access to COVID-19 vaccines for all countries through COVAX – noting that equitable access is essential to end the acute stage of the pandemic.

27 Sep 2021

WHO emphasizes the necessity to address acute health needs in Afghanistan

We recently completed a high level mission to Kabul, Afghanistan, where we met with senior members of the Taliban leadership, UN partners, health care workers and patients, and WHO staff.

27 Sep 2021

Factors predicting vaccine hesitancy in India

A recent study discusses vaccine hesitancy in India, which is one of the most populous countries in the world.

26 Sep 2021

Hepatitis B in newborns is a public health issue in the Pacific islands

The Pacific island nations are falling back on immunization targets, especially those for diseases spread through mother-to-child transmission, according to WHO officials.

24 Sep 2021

CDC endorses ACIP recommendation for Pfizer-BioNTech COVID-19 booster shot

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings.

24 Sep 2021

Exploring the polymerase of poxviruses at an atomic level

Poxviruses have found a unique way of translating their genes into proteins in the infected organism. A team of researchers from Würzburg shows for the first time how the molecular machinery involved works at an atomic level.

24 Sep 2021

COVID-19 vaccination and lactation

A new study evaluates the presence of antibodies in breastmilk and the immune responses of lactating women after vaccination of the COVID-19 vaccine.

23 Sep 2021

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

Researchers in Canada, Italy, and the United States have encouraged extending the interval time between two doses of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine among individuals who have not previously been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2021

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.

22 Sep 2021

The impact of the COVID-19 pandemic on access to vaccines during pregnancy

A new preprint discusses how women felt during the pandemic as they struggled to gain access to safe vaccination for themselves and for their babies.

21 Sep 2021

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Researchers in the United States have conducted a study showing that the antibody response to vaccination designed to protect against coronavirus disease 2019 (COVID-19) wanes substantially over time among patients receiving maintenance dialysis.

21 Sep 2021

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have addressed the gap in the research regarding the adverse reactions to the COVID-19 vaccine among individuals with allergies.

20 Sep 2021

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

In a study available on the preprint server medRxiv*, researchers have created a vaccine designed to overcome issues associated with attenuated-virus vaccines.

17 Sep 2021

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

In January — long before the first jabs of covid-19 vaccine were even available to most Americans — scientists working under Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases were already thinking about potential booster shots.

16 Sep 2021

Immunization News and Research

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

Pfizer-BioNTech’s COVID-19 vaccine appears effective against SARS-CoV-2 mu variant

Enterovirus 71 vaccine candidate strains exhibit good immunogenicity and cross-neutralization activity

Trial of Sanofi/GSK SARS-CoV-2 vaccine boosters against variants in non-human primates

Who qualifies for a covid booster? The list is growing longer

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

WHO emphasizes the necessity to address acute health needs in Afghanistan

Factors predicting vaccine hesitancy in India

Hepatitis B in newborns is a public health issue in the Pacific islands

CDC endorses ACIP recommendation for Pfizer-BioNTech COVID-19 booster shot

Exploring the polymerase of poxviruses at an atomic level

COVID-19 vaccination and lactation

Researchers encourage longer dosing intervals for Pfizer-BioNTech’s COVID-19 vaccine

mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

The impact of the COVID-19 pandemic on access to vaccines during pregnancy

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News